Affimed NV
AFMD0.181USD
0.000
Fechamento 11/04, 16:00（ET）Cotações atrasadas em 15 min
2.98MValor de mercado
PerdaP/L TTM
Mais detalhes de Affimed NV Empresa
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its pipeline includes AFM13, AFM13 + adoptive NK cells, AFM13 + anti-PD-1, AMF24, AMF26, AMF28 and AMF32. The Company is enrolling patients into a registration-directed study of AFM13 for CD30-positive relapsed/refractory peripheral T-cell Lymphoma and into a Phase 1/2a dose escalation/expansion study of AFM24 for the treatment of advanced EGFR-expressing solid tumors. Its preclinical product candidates include AMF26 for treating multiple myeloma, as well as AMF28 and AMF32, for treating of multiple tumor targets. In addition, the Company collaborates with Genentech to develop and commercialize certain product candidates for treating multiple cancers.
Informações de Affimed NV
Código da empresaAFMD
Nome da EmpresaAffimed NV
Data de listagemSep 12, 2014
CEOMr. Shawn M. Leland
Número de funcionários76
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 12
EndereçoIm Neuenheimer Feld 582
CidadeHEIDELBERG
Bolsa de valoresBerne Stock Exchange
PaísGermany
Código postal69120
Telefone49621560030
Sitehttps://www.affimed.com/
Código da empresaAFMD
Data de listagemSep 12, 2014
CEOMr. Shawn M. Leland
Executivos da empresa Affimed NV
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Wolfgang Fischer, Ph.D.
Dr. Wolfgang Fischer, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
145.54K
+34.45%
Ms. Denise Mueller
Ms. Denise Mueller
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
89.88K
+65.92%
Dr. Andreas Harstrick, M.D.
Dr. Andreas Harstrick, M.D.
Chief Medical Officer, Member of the Management Board
Chief Medical Officer, Member of the Management Board
76.04K
+88.54%
Dr. Mathieu Simon
Dr. Mathieu Simon
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.00K
+36.36%
Mr. Harry Welten
Mr. Harry Welten
Consulting Chief Financial Officer, Member of the Management Board
Consulting Chief Financial Officer, Member of the Management Board
15.00K
+36.36%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
14.00K
+16.67%
Ms. Uta Kemmerich-Keil
Ms. Uta Kemmerich-Keil
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
11.00K
+83.33%
Mr. Shawn M. Leland
Mr. Shawn M. Leland
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Bernhard R. M. Ehmer
Dr. Bernhard R. M. Ehmer
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Thomas Hecht, M.D.
Dr. Thomas Hecht, M.D.
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Wolfgang Fischer, Ph.D.
Dr. Wolfgang Fischer, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
145.54K
+34.45%
Ms. Denise Mueller
Ms. Denise Mueller
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
89.88K
+65.92%
Dr. Andreas Harstrick, M.D.
Dr. Andreas Harstrick, M.D.
Chief Medical Officer, Member of the Management Board
Chief Medical Officer, Member of the Management Board
76.04K
+88.54%
Dr. Mathieu Simon
Dr. Mathieu Simon
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.00K
+36.36%
Mr. Harry Welten
Mr. Harry Welten
Consulting Chief Financial Officer, Member of the Management Board
Consulting Chief Financial Officer, Member of the Management Board
15.00K
+36.36%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
14.00K
+16.67%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Collaboration revenue
155.00K
0.00%
Service revenue
0.00
0.00%
Por RegiãoUSD
Nome
Receita
Proporção
United States
155.00K
100.00%
Germany
0.00
0.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Collaboration revenue
155.00K
0.00%
Service revenue
0.00
0.00%
Distribuição de ações
Atualizado em: sáb, 23 de ago
Atualizado em: sáb, 23 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Gilde Healthcare Partners B.V.
5.34%
Hoess (Adi Ph.D.)
2.10%
Fischer (Wolfgang)
0.96%
Mueller (Denise)
0.59%
Schottelius (Arndt)
0.55%
Outro
90.47%
Investidores
Investidores
Proporção
Gilde Healthcare Partners B.V.
5.34%
Hoess (Adi Ph.D.)
2.10%
Fischer (Wolfgang)
0.96%
Mueller (Denise)
0.59%
Schottelius (Arndt)
0.55%
Outro
90.47%
Tipos de investidores
Investidores
Proporção
Individual Investor
6.01%
Venture Capital
5.34%
Investment Advisor
0.08%
Outro
88.58%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
108
824.54K
5.41%
-4.99M
2025Q2
144
3.74M
24.53%
-2.97M
2025Q1
194
5.44M
35.72%
-1.40M
2024Q4
223
4.37M
28.70%
-3.86M
2024Q3
244
6.36M
129.59%
-2.88M
2024Q2
256
6.34M
129.44%
-2.70M
2024Q1
265
6.05M
127.57%
-3.49M
2023Q4
282
6.20M
128.84%
-3.49M
2023Q3
294
6.99M
46.94%
-2.84M
2023Q2
315
7.55M
50.71%
-3.53M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Gilde Healthcare Partners B.V.
812.50K
5.34%
+812.50K
--
Mar 15, 2024
Hoess (Adi Ph.D.)
319.68K
2.1%
+66.08K
+26.06%
Mar 15, 2024
Fischer (Wolfgang)
145.54K
0.96%
+37.29K
+34.45%
Mar 15, 2024
Mueller (Denise)
89.88K
0.59%
+35.71K
+65.92%
Mar 15, 2024
Schottelius (Arndt)
83.54K
0.55%
+35.71K
+74.65%
Mar 15, 2024
Harstrick (Andreas)
76.04K
0.5%
+35.71K
+88.54%
Mar 15, 2024
Smith (Angus W)
65.71K
0.43%
+13.29K
+25.36%
Mar 15, 2024
Hecht (Thomas M.D.)
38.54K
0.25%
+4.50K
+13.22%
Mar 15, 2024
Ehmer (Bernhard R M)
20.83K
0.14%
+3.00K
+16.82%
Mar 15, 2024
Grau (Ulrich Michael)
20.00K
0.13%
+3.00K
+17.65%
Mar 15, 2024
Ver Mais
ETFs Relacionados
Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
Fidelity Enhanced Small Cap ETF
0%
SPDR S&P International Small Cap ETF
0%
SPDR Portfolio Developed World ex-US ETF
0%
Fidelity Enhanced Small Cap ETF
Proporção0%
SPDR S&P International Small Cap ETF
Proporção0%
SPDR Portfolio Developed World ex-US ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Mar 06, 2024
Merger
10→1
Mar 06, 2024
Merger
10→1
Mar 06, 2024
Merger
10→1
Mar 06, 2024
Merger
10→1
Data
Tipo
Proporção
Mar 06, 2024
Merger
10→1
Mar 06, 2024
Merger
10→1
Mar 06, 2024
Merger
10→1
Mar 06, 2024
Merger
10→1
